Form 4: VYNE Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Mona Ashiya, a Director of VYNE Therapeutics Inc., received 15,435 shares of common stock on July 27, 2026.
Summary
- Grant/award: acquired 15,435 Stock Option (Right to Buy) on July 27, 2026; holds 15,435 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Mona Ashiya — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-27 | Grant/award | Stock Option (Right to Buy) | 15,435 | — | — | 15,435 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-27 | Grant/award (15,435 shares) |
Keywords
insider transaction, Form 4, YARW, Yarrow Bioscience, Inc., neutral, Mona Ashiya
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.